Literature DB >> 15507701

Detection and quantification of the rare latently infected cell undergoing herpes simplex virus transcriptional activation in the nervous system in vivo.

Nancy M Sawtell1.   

Abstract

Herpes simplex virus (HSV), in contrast to most other members of the herpes virus family, has the ability to infect, enter latency, and reactivate from latency in a number of nonhuman species, including mice. This provides a unique opportunity to study the complex lytic-latent cycle of a human neurotropic virus in a mouse model. This chapter details basic methods for inducing and quantifying reactivation, with emphasis on the first strategy for detecting and quantifying the initiation of HSV reactivation in vivo.

Entities:  

Mesh:

Year:  2005        PMID: 15507701     DOI: 10.1385/1-59259-848-x:057

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

2.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

4.  Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis.

Authors:  Leigh Zerboni; Xibing Che; Mike Reichelt; Yanli Qiao; Haidong Gu; Ann Arvin
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

5.  ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Authors:  William P Halford; Carla Weisend; Jennifer Grace; Mark Soboleski; Daniel J J Carr; John W Balliet; Yumi Imai; Todd P Margolis; Bryan M Gebhardt
Journal:  Virol J       Date:  2006-06-09       Impact factor: 4.099

6.  Analysis of Herpes Simplex Virus Reactivation in Explant Reveals a Method-Dependent Difference in Measured Timing of Reactivation.

Authors:  Jessica R Doll; Nancy M Sawtell
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia.

Authors:  Chung H Dang; Martine Aubert; Harshana S De Silva Feelixge; Kurt Diem; Michelle A Loprieno; Pavitra Roychoudhury; Daniel Stone; Keith R Jerome
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

8.  De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.

Authors:  Richard L Thompson; Chris M Preston; Nancy M Sawtell
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

Review 9.  Herpes simplex virus and the lexicon of latency and reactivation: a call for defining terms and building an integrated collective framework.

Authors:  Nancy M Sawtell; Richard L Thompson
Journal:  F1000Res       Date:  2016-08-19

10.  Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes.

Authors:  Utsav Pandey; Daniel W Renner; Richard L Thompson; Moriah L Szpara; Nancy M Sawtell
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.